Home › Funds › Logos Global Management LP › DSGN

Logos Global Management LP position in DSGN

DESIGN THERAPEUTICS INC · Health Care

Logos Global Management LP reported holding 3,000,000 shares of DSGN (DESIGN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$43.4M, representing 1.87% of its reported portfolio and ranking #17 among its reported holdings. Logos Global Management LP has disclosed DSGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.00M sh
Reported value held$43.41M
Portfolio Weight1.87%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's DSGN position evolved

Logos Global Management LP first disclosed a stake in DSGN in Q3 2023 at 5,032,501 shares (US$11.9M). The position peaked in Q2 2026 at 3,000,000 shares, worth US$43.4M. Across 12 filings, Logos Global Management LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 3,000,000 shares valued at US$43.4M — an increase of 1,050,000 shares quarter over quarter.. Notable position changes include a 32% trim in Q4 2025 (shares rose 13% over the following quarter), a 54% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.03M $11.88M New
Q4 2023 5.03M $13.34M Hold
Q1 2024 5.03M $20.28M Hold
Q2 2024 5.03M $16.86M Hold
Q3 2024 4.22M $22.69M Reduce
Q4 2024 4.22M $26.02M Hold
Q1 2025 4.22M $16.28M Hold
Q2 2025 4.22M $14.21M Hold
Q3 2025 3.65M $27.52M Reduce
Q4 2025 2.50M $23.45M Reduce
Q1 2026 1.95M $20.75M Reduce
Q2 2026 3.00M $43.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DSGN and 13F data

DSGN (DESIGN THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in DSGN — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$94.4M), BAKER BROS. ADVISORS LP (US$38.8M), Trails Edge Capital Partners, LP (US$29.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DSGN

All DSGN fund holders →

FAQ

How long has Logos Global Management LP held DSGN?

Logos Global Management LP has disclosed DSGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in DSGN?

As of Q2 2026, Logos Global Management LP holds 3.00M shares of DSGN (DESIGN THERAPEUTICS INC), valued at $43.41M, representing 1.87% of its reported portfolio and ranking #17.

Has Logos Global Management LP been buying or selling DSGN?

In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in DSGN. The position peaked in Q2 2026 at 3.00M shares.

Which other funds hold DSGN?

Other major institutional holders of DSGN include SR ONE CAPITAL MANAGEMENT, LP, BAKER BROS. ADVISORS LP, Trails Edge Capital Partners, LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.